Aeon Global Health Names Michael J. Poelking as Chief Financial Officer and Treasurer

GAINESVILLE, Ga., Sept. 13, 2017 /PRNewswire/ -- Authentidate Holding Corp. (OTCQB: ADAT), a growth oriented company focused on developing and providing clinically actionable medical information and telemedicine services, announced today that Michael J. Poelking, has been promoted to the position of Chief Financial Officer and Treasurer. Mr. Poelking, who recently joined Aeon Global Health as Senior Director of Finance, will have full responsibility for the Company's financial operations and reporting functions.

Mr. Poelking, 61, has extensive expertise in the health care finance field with both large and small companies. Prior to joining Aeon, he provided CFO consulting services to One Direct Health Network, Inc., an early stage medical service company specializing in the home health industry. He also served as CFO of Amendia, Inc., a firm which designs and markets Class II and Class III medical devices, paired with biologics distribution. In that role, Mr. Poelking participated in the successful closing of five M&A transactions and the successful sale of the company to Kohlberg and Company, a New York based private equity firm. Earlier in his career, he held finance and senior operations positions with several other medium-sized healthcare organizations, as well as at Wilson Sporting Goods Company, where he was the Director of Corporate Accounting & Reporting.  Mr. Poelking received a Master in Business Administration and B.B.A. in Accounting from Loyola University Chicago.

"We are excited to announce Michael's promotion to Chief Financial Officer," said Sonny Roshan, Aeon's Founder, Chairman and CEO. "In the brief time that Michael has been part of the Aeon management team, he has demonstrated the leadership and expertise necessary to drive our financial function forward.  He has already implemented a number of enhancements to our financial operations so that we can be positioned for the rapid growth that we anticipate."

"Michael's broad experience, not only in finance, but on the operational side as well, will be invaluable as we advance Aeon's strategic growth plan," said David Goldberg, Aeon's Chief Operating Officer.  "We will rely on his leadership and expertise as we look to not only strengthen our core business, but also as we seek to expand via acquisitions, joint ventures and partnerships," he added.

ABOUT AUTHENTIDATE/AEON GLOBAL HEALTH
Authentidate Holding Corp. (OTCQB: ADAT), through its Aeon Global Health operating arm, is an emerging leader in the provision of clinically actionable medical informatics. Founded in 2010, Aeon is focused on the delivery of services consistent with federal quality standards and which exceed industry standards for turn-around time. Operating out of a modern 30,000 square-foot facility in suburban Atlanta, the Company provides a comprehensive menu of diagnostic and laboratory- developed tests as well as interpretative data for a wide range of inherited conditions.

Except for historical information, the matters discussed in this press release may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this release, words such as "believe", anticipate" think", "intend", "plan", "will be", "expect" or similar expressions identify such forward looking statements. In addition, such statements include declarations regarding the intent, belief or current expectations of Authentidate Holding Corp. and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, for example, the markets for the Company's services, costs of and services, other expenses, government regulations, litigation, and general business conditions. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and that actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control.  Other risks and uncertainties are more fully described in our reports filed with the SEC. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The statements made in this press release speak only as of the date stated herein, and subsequent events and developments may cause our expectations and beliefs to change. Unless otherwise required by applicable securities laws, we do not intend, nor do we undertake any obligation, to update or revise any forward-looking statements contained in this news release to reflect subsequent information, events, results or circumstances or otherwise.

SOURCE Aeon Global Health